In SCD mice, inhibition of TLR4 signaling using the small molecule inhibitor TAK-242 reduces microvascular stasis in presence of hemin, LPS, and hypoxia/reoxygenation (H/R) (8, 9). This evidence concerns the gene TLR4 and Schnyder corneal dystrophy.